Work

Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs

Year: 2013

Type: article

Source: Leukemia

DOI: 10.1038/leu.2013.194

Authors: D Cirstea, T Hideshima, L Santo, H Eda, Y Mishima, N Nemani, Y Hu, N Mimura, F Cottini, G Gorgun, H Ohguchi, R Suzuki, H Loferer, N C Munshi, K C Anderson, N Raje

Institutions: Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: SPORE in Multiple Myeloma, Integrative Oncogenomics of Multiple Myeloma

OpenAlex ID: W2140277695

FWCI: 4.987

Cites: 41

Cited by: 58

Related to: 10